- Home
- BOTJ vs ALDX Comparison
BOTJ vs ALDX Comparison
Compare BOTJ & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOTJ | ALDX |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.9M | 95.7M |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BOTJ | ALDX |
|---|---|---|
| Price | $22.00 | $1.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 6.1K | ★ 5.9M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.99% | N/A |
| EPS Growth | 13.71 | ★ 40.43 |
| EPS | ★ 1.99 | N/A |
| Revenue | ★ $4,273,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.12 | ★ N/A |
| Revenue Growth | ★ 6.74 | N/A |
| 52 Week Low | $13.03 | $1.07 |
| 52 Week High | $23.00 | $6.18 |
Technical Indicators
Market Signals| Indicator | BOTJ | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 62.15 | 35.42 |
| Support Level | $20.18 | $1.48 |
| Resistance Level | N/A | $2.33 |
| Average True Range (ATR) | 0.57 | 0.12 |
| MACD | 0.09 | 0.13 |
| Stochastic Oscillator | 66.04 | 81.71 |
Price Performance
Historical ComparisonAbout BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.